Short Sellers are WRONG AGAIN, $NNOX gets 510K Approval for Single Source

Andrew Kamal
QuantPortal
Published in
2 min readApr 2, 2021

Short sellers have lead people to believe that Nanox either didn’t submit anything to the FDA or will get rejected for its 510(k). Some of them started caving in and said even if they get 510(k) for single source it means nothing. On Stocktwits and other social media sites they have pushed people into thinking buying $15 puts or options contracts for next week is a good idea, and either surely they will get rejected or $NNOX submitted nothing.

Their sheer arrogance and over confidence have made many people worried. However, me and many other people who were looking into Nanox for a long time stood confident in the company. Nanox has just announced 510(k) approval putting an end to this bear thesis. Most likely short sellers may come and go again as is inevitable with many innovative companies. However, with companies that continue to innovate, I am not worried at all.

I do engage in research related to the sensory tech and medical device industry. However, I hold no relations to Nanox Imaging or working with Nanox Imaging. My only current conflict of interest is being long on its stock.

Disclosure: Please keep in mind, everything I say is on an opinion based basis. This is not meant to be taken seriously or as actionable financial advice. Do your own due diligence and any trades/investments you do is at your own risk. We are not responsible, proceed with caution and we are trying to voice an opinion not meant to warrant action. This is solely meant to be viewed as a non actionable opinion not meant to be taken as seriously or as a form of actionable advice.

--

--

Andrew Kamal
QuantPortal

The dude with many different talents *Coder *Inventor *Startup Advisor *Coptic Activist *Sponsored Athlete *Blogger *Conservative *Researcher *Miaphysite